Proteomic Profiling of Diffuse Large B-Cell Lymphomas

Autor: Ann Kaufeldt, Svetlana Bajalica-Lagercrantz, Serhiy Souchelnytskyi, Catharina Larsson, Nazariy Souchelnytskyi, Anna Kwiecinska, Anna Porwit
Rok vydání: 2017
Předmět:
BiP/Grp78
0301 basic medicine
Adult
Male
Proteomics
Germinal center type
Hsp90
Biology
Pathology and Forensic Medicine
03 medical and health sciences
0302 clinical medicine
immune system diseases
hemic and lymphatic diseases
medicine
Biomarkers
Tumor

De novo diffuse large B-cell lymphomas
Humans
Cyclin B2
Non-germinal center type
Molecular Biology
Endoplasmic Reticulum Chaperone BiP
B cell
Aged
Gel electrophoresis
Aged
80 and over

proteomics
cancer

Tissue microarray
Proteomic Profiling
Gene Expression Profiling
Diffuse large B-cell lymphoma
Cell Biology
General Medicine
Middle Aged
medicine.disease
Molecular biology
Lymphoma
Transformed lymphoma
030104 developmental biology
medicine.anatomical_structure
030220 oncology & carcinogenesis
Child
Preschool

Proteome
Female
Lymphoma
Large B-Cell
Diffuse
Zdroj: Pathobiology : journal of immunopathology, molecular and cellular biology. 85(4)
ISSN: 1423-0291
Popis: Objective: The aim of this study was to identify differences in proteome profiles of diffuse large B-cell lymphoma (DLBCL) of nongerminal center (non-GC) versus GC type in the search for new markers and drug targets. Methods: Six DLBCL, with 3 repeats for each, were used for the initial study by proteomics: 3 non-GC and 3 GC DLBCL cases. For immunohistochemistry, tissue microarrays were made from 31 DLBCL samples: 16 non-GC de novo lymphomas and 15 GC cases (11 transformed from follicular lymphomas and 4 de novo GC lymphomas). Proteome profiling was performed by two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry. Results: Ninety-one proteins were found differentially expressed in non-GC compared to GC type. The Cytoscape tool was used for systemic analysis of proteomics data, revealing 19 subnetworks representing functions affected in non-GC versus GC types of DLBCL. Conclusion: A validation study of 3 selected proteins (BiP/Grp78, Hsp90, and cyclin B2) showed the enhanced expression in non-GC DLBCL, supporting the proteomics data.
Databáze: OpenAIRE